-
A651846-5mgAleplasinin is an orally active, potent, BBB-penetrated and selective SERPINE1 ( PAI-1 , Plasminogen activator inhibitor-1) inhibitor. Aleplasinin increases amyloid-β (Aβ) catabolism and ameliorates amyloid-related pathology. Aleplasinin improves
-
A647057-10mgAlicapistat (ABT-957) is an orally active selective inhibitor of human calpains 1 and 2 for the potential application of Alzheimer's disease (AD) Alicapistat mitigates the metabolic liability of carbonyl reduction and inhibits calpain 1 with an IC
-
A647057-5mgAlicapistat (ABT-957) is an orally active selective inhibitor of human calpains 1 and 2 for the potential application of Alzheimer's disease (AD) Alicapistat mitigates the metabolic liability of carbonyl reduction and inhibits calpain 1 with an IC
-
A151143-100mgAlimemazine Tartrate.
-
A151143-1gAlimemazine Tartrate.
-
A151143-5gAlimemazine Tartrate.
-
A647300-10mgAlimemazine-d 6 is deuterium labeled Alimemazine, which is an antihistamine.Form:Solid.
-
A647300-1mgAlimemazine-d 6 is deuterium labeled Alimemazine, which is an antihistamine.Form:Solid.
-
A647300-5mgAlimemazine-d 6 is deuterium labeled Alimemazine, which is an antihistamine.Form:Solid.
-
A647986-1mgAlisporivir (Debio-025) is a cyclophilin inhibitor molecule with potent anti-hepatitis C virus ( HCV ) activity.In VitroDEB025 binds to CypA, a peptidyl-prolyl cis-trans isomerase which is a crucial cofactor for HCV replication. Alisporivir
-
A647986-5mgAlisporivir (Debio-025) is a cyclophilin inhibitor molecule with potent anti-hepatitis C virus ( HCV ) activity.In VitroDEB025 binds to CypA, a peptidyl-prolyl cis-trans isomerase which is a crucial cofactor for HCV replication. Alisporivir
-
A648931-100mgALK2-IN-2 is a potent and selective inhibitor of activin receptor-like kinase 2 (ALK2) with an IC 50 of 9 nM, and over 700-fold selectivity against ALK3Form:SolidIC50&: Target:ACVR1 9 nM (IC 50 ).